- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14:58 | NHS study will pick apart mental illness with data science | ||
| 13:58 | Compass points to strong psilocybin data in depression | ||
| 12:58 | EU approval for new asthma drug Exdensur lifts GSK | ||
| 12:58 | Mark Dawson named head of Roche's pRED unit | ||
| 11:58 | Helus' psychedelic drug DMT 'could help treat depression' | ||
| Mo | UK seeks views on indefinite CE marks for medical devices | ||
| Mo | Roche trial offers hope to patients with rare kidney disease | ||
| Mo | AI in drug development news round-up | ||
| Mo | FDA turns down 'national priority' drug from Disc Medicine | ||
| Mo | Report says Jim O'Neill's time at HHS is nearing its end | ||
| Fr | Bankruptcy threat looms as Quince runs out of options | ||
| Fr | Lundbeck preps phase 3 for migraine prevention drug | ||
| Fr | PTC pulls file for Duchenne therapy on FDA feedback | ||
| Fr | ILiAD bags $115m for pertussis vaccine, and other financings | ||
| Do | BridgeBio gains on phase 3 dwarfism data | ||
| Do | Euro VCs team up to invigorate life sciences ecosystem | ||
| Do | Zydus follows Lupin with Myrbetriq settlement deal | ||
| Do | FDA says comparator dose scuppered Moderna's flu jab filing | ||
| Do | Hudson out at Sanofi, as Belén Garijo named CEO | ||
| Mi | Madrigal builds in MASH with $4.4bn+ Ribo alliance | ||
| Mi | Inept digital interaction undermining pharma with clinicians | ||
| Mi | Novo Nordisk's Wegovy pill ad 'misleading', says FDA | ||
| Mi | Moderna cries foul as FDA blocks filing of mRNA flu shot | ||
| Mi | UK moves ahead with GP patient data sharing plan | ||
| 10.02. | FDA kicks off review of Takeda's narcolepsy hopeful |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.